Group 1: Overseas Market Growth - The company achieved revenue of 327 million CNY in the overseas market in the first half of 2025, representing a year-on-year growth of 34% [2] - Key factors for this growth include the implementation of a major client strategy and the establishment of stable partnerships with top clients, particularly in the European and African markets [2][3] - The company has improved its global operational management system, enhancing overall efficiency in overseas business operations [2] Group 2: Product Development and Innovation - In 2025, the company focused on core materials such as dental zirconia blocks, with significant advancements in digital dental equipment, gaining high market recognition [3] - New business segments, including digital full-arch dentures and 3D printing, have made breakthroughs in both product and market aspects [3][4] - The company plans to increase investment in equipment business to further enhance competitiveness [3] Group 3: Capacity Expansion and Management - The company has seen a continuous increase in order demand, with high capacity utilization rates [4] - New production capacity will be released in phases according to market demand and order growth, ensuring a precise match between capacity release and order growth [4] Group 4: Profitability and Margin Strategies - The gross margin in overseas markets is higher than in domestic markets due to differences in product structure and benefits from export tax rebates [4] - The company has established a three-dimensional strategy to enhance gross margins, focusing on R&D innovation, cost reduction in production, and supply chain collaboration [4]

Group 1 - Huaseng Tiancheng's revenue from AI-related business currently accounts for a low proportion of the company's overall operating income [1] - Xinhua Department Store has no plans to inject assets related to semiconductors, integrated circuits, or chips into the company [1] - Triangle Tire plans to invest 3.219 billion yuan to establish a new project in Cambodia with an annual production capacity of 7 million high-performance radial tires [1] Group 2 - Tianhong Co., Ltd.'s subsidiary has won a bid for an AI service procurement project from AVIC Technology [1] - Xinghua New Materials intends to acquire at least 51% of Tian Kuan Technology's shares [1] - Luxshare Precision plans to repurchase company shares worth between 1 billion to 2 billion yuan [1] Group 3 - Rui Zhi Pharmaceutical's Liang Yufeng and Yu Xianwen plan to collectively reduce their holdings by no more than 6% [1] - Tian Sheng New Materials plans to raise no more than 253 million yuan through a private placement to Rongsheng Zhizhi [1] - Zhongchuang Zhiling intends to issue convertible bonds to raise no more than 4.35 billion yuan for investment in high-end components for the new energy vehicle industry [2]

Group 1 - The core point of the article is that Aidi Te (301580.SZ) announced a share reduction plan by Junlian Xinkang and HAL, which will take place within three months after the announcement [1] - The total number of shares to be reduced is up to 3,196,930 shares, accounting for 3.0000% of the company's total share capital [1] - The reduction will occur through two methods: a maximum of 1,065,640 shares (1.0000% of total share capital) will be sold via centralized bidding, and up to 2,131,290 shares (2.0000% of total share capital) will be sold through block trading [1]

Core Viewpoint - The company Aidi Te (爱迪特) announced that its major shareholders, Suzhou Junlian Xinkang Venture Capital Partnership and HAL, plan to reduce their holdings by a total of up to 3.1969 million shares, representing 3% of the company's total equity [1] Summary by Categories Shareholder Actions - Major shareholders intend to reduce their holdings through centralized bidding or block trading [1] - The planned reduction includes up to 1.0656 million shares via centralized bidding and up to 2.1313 million shares through block trading [1] Timeline - The reduction period is set for three months starting from 15 trading days after the announcement date [1] Source of Shares - The shares to be reduced are sourced from those acquired before the initial public offering and from capital reserves converted into equity after the listing [1]

证券代码：301580 证券简称：爱迪特 公告编号：2026-001 爱迪特（秦皇岛）科技股份有限公司 关于持股 5%以上股东减持股份预披露公告 股东苏州君联欣康创业投资合伙企业（有限合伙）和 HEALTH ADVANCE LIMITED 保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 爱迪特（秦皇岛）科技股份有限公司（以下简称"公司"）股东苏州君联欣 康创业投资合伙企业（有限合伙）（以下简称"君联欣康"）以及康拓有限公司 （HEALTH ADVANCE LIMITED）（以下简称"HAL"）为公司首次公开发行 股票上市前股东，合计持有公司股份 10,656,043 股（占公司总股本比例为 9.9996%)。君联欣康和 HAL 构成一致行动人关系，减持时按照一致行动人相关 规则进行信息披露。 君联欣康属于创业投资基金，已获得中国证券投资基金业协会备案，符合《上 市公司创业投资基金股东减持股份的特别规定（2020 年修订）》《深圳证券交 易所上市公司创业投资基金股东减持股份实施细则（2020 年修 ...

深圳证券交易所： 中信建投证券股份有限公司（以下简称"保荐机构"）作为爱迪特（秦皇岛） 科技股份有限公司（简称"爱迪特"、"公司"）首次公开发行股票并在创业板上 市的保荐机构和持续督导机构，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第13号— —保荐业务》等有关规定，于2025年12月26日对爱迪特董事、高级管理人员及实际 控制人等进行了培训，培训情况如下： 中信建投证券股份有限公司 关于爱迪特（秦皇岛）科技股份有限公司 2025年度持续督导培训报告 三、培训的完成情况及效果 一、培训的时间、地点及参会人员 时间：2025年12月26日 地点：爱迪特会议室及线上会议 参会人员：全体董事、高级管理人员及实际控制人等 二、培训的主要内容 本次培训内容主要包括： 1、上市公司募集资金的存放使用及管理要求； 2、上市公司募集资金警示性处罚案例的分享； 3、上市公司信息披露相关规定及违规的典型案例。 本次持续督导培训的工作过程中，全体参与培训人员均进行了认真深入学习， 对于上市公司的规范运营、募集资金管理等有了更加深刻的认识。本次培训达到了 预期的目标 ...

Core Viewpoint - The company is exploring the application of zirconia materials and 3D printing technology in the medical field, particularly in personalized cranial fixation and bone repair, aligning with the trends of domestic biomedical material development and customized 3D printing [1] Group 1: Company Strategy - The company currently focuses on developing 3D printing materials primarily for the dental medical field, including resins for models, gums, and guides, as well as related printing equipment [1] - The company expresses a commitment to actively explore the application of 3D printing zirconia technology in relevant medical fields [1]

Core Viewpoint - The company is focusing on the development and production of 3D printing materials primarily for the dental medical field, including resins for models, gums, and guides, as well as related printing equipment [1] Group 1: Company Focus - The company is actively exploring the application of 3D printing zirconia technology in relevant medical fields [1]

Core Viewpoint - The company is focusing on the development and production of 3D printing materials primarily for the dental medical field, including resins for models, gums, guides, and related printing equipment [1] Group 1 - The company is actively exploring the application of 3D printing zirconia technology in relevant medical fields [1]

Group 1 - On January 7, 21 companies were investigated by institutions, with 19 of them being attended by funds, highlighting a strong interest in specific companies like Chaojie Co., Shunhao Co., and Dongfang Shenghong [1][2] - Chaojie Co. received the most attention, with 27 funds participating in its investigation, while Shunhao Co. and Dongfang Shenghong had 18 and 13 funds respectively [1][3] - The companies investigated belong to various sectors, with the electronics and machinery equipment industries having the highest representation, each with 3 companies [1] Group 2 - Among the companies investigated, 3 have a total market capitalization exceeding 500 billion yuan, with BOE Technology Group being one of them, while 8 companies have a market cap below 100 million yuan [1] - In terms of market performance, 14 out of the investigated stocks increased in value over the past 5 days, with the highest gains seen in Pulite, Shunhao Co., and Guanglian Aviation, which rose by 38.07%, 20.57%, and 13.49% respectively [1][2] - Conversely, 4 stocks experienced declines, with the largest drops recorded by Binglun Environment, Haixia Co., and Dongfang Shenghong, which fell by 11.15%, 10.70%, and 2.09% respectively [1]